16-89195079-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_004933.3(CDH15):c.2369C>T(p.Ala790Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000236 in 1,611,792 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004933.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDH15 | NM_004933.3 | c.2369C>T | p.Ala790Val | missense_variant | 14/14 | ENST00000289746.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDH15 | ENST00000289746.3 | c.2369C>T | p.Ala790Val | missense_variant | 14/14 | 1 | NM_004933.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000218 AC: 54AN: 248094Hom.: 0 AF XY: 0.000237 AC XY: 32AN XY: 134848
GnomAD4 exome AF: 0.000243 AC: 355AN: 1459614Hom.: 0 Cov.: 31 AF XY: 0.000258 AC XY: 187AN XY: 725988
GnomAD4 genome AF: 0.000171 AC: 26AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Feb 21, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2024 | The c.2369C>T (p.A790V) alteration is located in exon 14 (coding exon 14) of the CDH15 gene. This alteration results from a C to T substitution at nucleotide position 2369, causing the alanine (A) at amino acid position 790 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | CDH15: BP4 - |
Intellectual disability, autosomal dominant 3 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at